Pneumococcal Conjugate Vaccine impact assessment in Bangladesh [version 1; referees: 1 approved, 2 approved with reservations]

The study examines the impact of the introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) into Bangladesh’s national vaccine program. PCV10 is administered to children under 1 year-old; the scheduled ages of administration are at 6, 10, and 18 weeks. The study is conducted in ~770,000 po...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Abdullah H. Baqui, Eric D. McCollum, Samir K. Saha, Arun K. Roy, Nabidul H. Chowdhury, Meagan Harrison, Abu Abdullah Mohammad Hanif, Nicole Simmons, Arif Mahmud, Nazma Begum, Salahuddin Ahmed, Ahad M. Khan, Zabed Bin Ahmed, Maksuda Islam, Dipak Mitra, Abdul Quaiyum, Miguel A. Chavez, Farhan Pervaiz, Catherine H. Miele, Holly B. Schuh, Rasheda Khanam, William Checkley, Lawrence H. Moulton, Mathuram Santosham
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: F1000 Research Ltd 2018-04-01
Saila:Gates Open Research
Sarrera elektronikoa:https://gatesopenresearch.org/articles/2-21/v1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak